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PASSIVE IMMUNITY TO VACCINIA IN NEWBORNS
I. PLACENTAL TRANSMISSION OF ANTIBODIES*
C. HENRY KEMPE**
A hemagglutination-inhibition test for the determination of vaccinia
antibodies in serum was first described by Nagler.5 It has been used exten-
sively by us in a standardized form.2 Collier8 has utilized a modification of
the method in his study of adults. The present report deals with the deter-
mination of the titre of vaccinia antibodies in the sera of 182 mothers at
term and in the cord blood of their newborn offsprings. Of the mothers,
102 had been vaccinated within the past five years, while 80 had been
vaccinated more than five years ago.
METHODS
A standardized procedure of determining vaccinia hemagglutination-inhibition anti-
bodies in serum has been described previously.2 A suspension of vaccinia-infected
allantoic membranes is used as the antigen. Fowl cells susceptible to hemagglutination
with the vaccinia-variola group of viruses are utilized in a concentration of 0.5 per
cent in Alsever's solution. A single hemagglutinating unit is defined as that dilution of
the antigen which produces definite hemagglutination of 0.25 cc. of a 0.5 per cent
suspension of vaccinia-sensitive fowl cells. The specificity of this reaction is shown as
follows:
(i) Serum of vaccinated individuals inhibits this agglutination to a reproducible
titre.
(ii) There is failure of inhibition of agglutination by sera of non-immune rabbits.
Sera for antibody determination are diluted in 10 Kahn tubes in two-fold dilution in
0.85 per cent saline solution (1:5 to 1:2560). The volume of diluted serum is 0.25 ml.
To the serum dilutions, 0.25 ml. of antigen dilution containing two hemagglutinating
units is added. Known positive and negative control sera are included. An antigen
control is set up in which the antigen dilution used in the test is diluted in saline.
Racks are shaken and incubated for one hour at 350 to 370 C. Then 0.25 ml. of 0.5
per cent fowl cell suspension is added, the racks shaken and allowed to stand at room
temperature until the cells are settled. After one hour, the pattern of sedimented cells
is examined. The greatest serum dilution which produces complete inhibition of agglu-
tination is recorded as the hemagglutination-inhibition titre of that serum. The tube
containing this dilution should present the same pattern as a control tube with 0.25 ml.
of vaccinia-sensitive red cell suspension and 0.5 ml. of saline. The negative control
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serum should show no inhibition of agglutination, while the positive control should
show inhibition within one dilution of its usual titre. Complement fixation tests also
were performed on 141 of the sera using two units of soluble vaccinia antigen, two
units of complement, with fixation for 2¼/2 hours at 370 C.
RESULTS
Serologic studies were performed on 182 mothers at term and on cord
bloods of their 182 newborn infants. Figure 1 shows the hemagglutination-
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FIG. 1. Hemagglutination-inhibition
titres in serum of 182 mothers at term
and on cord bloods of their newborn
infants.
As a group, infants have consistently
higher antibody titres than their mothers.
Mothers vaccinated within five years
have titres higher than those vaccinated
earlier, as do their respective groups of
infants.
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CHART 1. Hemagglutination-inhibition
titres in serum of 102 mothers (vac-
cinated within five years) and their
newborn infants.
Figures represent the number of in-
stances in which the mother's titre and
that of her newborn infant were found
at the levels indicated. All numbers
within the blocked area represent in-
stances in which the mother's titre was
found to be identical to that of her in-
fant. Numbers to the right of the
blocked area indicate instances in which
the infants' titres were significantly
higher than their mothers'.
inhibition titers of these sera. For purposes of analysis these individuals
were placed in one of four groups:
(i) 102 mothers vaccinated within the past five years;
(ii) their 102 newborn infants;
(iii) 80 mothers vaccinated more than five years ago;
(iv) their 80 newborn infants.
The data are plotted in terms of per cent of individuals with titres less
than any chosen level.
Figure 1 shows that only 20 per cent of the mothers vaccinated within
the past five years had hemagglutination-inhibition titres greater than 1:80,
while 48 per cent of their newborn infants had titres above that level. Only
14 per cent of the mothers vaccinated more than five years ago had titres
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greater than 1:20, while 38 per cent of their newborn infants had titres
above this level.
Chart 1 and Chart 2 give the number of instances in which the mother's
titer is present at a given level, when plotted against the titer of the serum
of her newborn infant. Chart 1 refers to the mothers vaccinated within five
years and their newborn infants; Chart 2 refers to the mothers vaccinated
more than five years ago and their infants. The area enclosed by the heavy
lines includes the instances where the titres of the mothers' serum and of
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CHART 2. Hemagglutination-inhibition
titres in serum of 80 mothers (vaccinated
over five years ago) and their newborn
infants.
Figures represent the number of in-
stances in which the mother's titre and
that of her newborn infant were found at
the levels indicated. All numbers within
the blocked area represent instances in
which the mother's titre was found to be
identical to that of her infant. Numbers
to the right of the blocked area indicate
instances in which the infants' titres were
significantly higher than their mothers'.
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CHART 3. Complement-fixation titres
in the serum of mothers and their in-
fants in 141 instances in which the
infants had shown higher hemagglu-
tination-inhibition titres than their
mothers.
The complement-fixation titres of
these infants is also significantly high-
er than those of their mothers.
their newborns are identical or differ by one dilution in either direction-
the latter differences being considered to be within the error of the test.
In the group shown in Chart 1, 41 out of 102 of the newborn infants have
titres significantly higher than their mothers, while only four of the 102 are
significantly lower. The results shown in Chart 2 indicate that 30 out of 80
have titres significantly higher than their mothers, while only one of the
80 is significantly lower.
In order to test whether these higher titres, in fact, represent specific
antivaccinia substance, complement-fixation tests also were performed on
the sera of 141 of the infants and their mothers. Chart 3 shows that, in
general, newborn infants who have hemagglutination-inhibition titres higher
than their mothers also show higher complement-fixation titres. Fairly good
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correlation between these two very distinct antibodies is apparent, indicat-
ing presence of a specific immune substance.
DISCUSSION
The findings of consistently higher antibody titres in the blood of
newborn infants, when compared to their own mothers, are of great interest
and are not readily explained. They suggest that actual immune substance is
being measured and this tends to be borne out by the preliminary experi-
ments subsequently described. The higher concentration may be explained
on the basis of concentration in the placenta and corresponding diaplacental
transfer. This has been discussed by Doerr.' Such passively transferred and,
perhaps, enhanced immunity immediately following smallpox vaccination
of the mother may have definite clinical significance in pediatrics.
SUMMARY
1. A comparison of the hemagglutination-inhibition titres of 182 mothers
at term and their newborn infants reveal consistently higher titres in the
infants in a significant number of cases.
2. Mothers vaccinated within the past five years have higher titres than
those vaccinated earlier.
3. Infants of mothers vaccinated within the past five years have signifi-
cantly higher titres than those whose mothers were vaccinated more than
five years ago.
II. RESPONSE TO VACCINATIONS
A preliminary attempt to evaluate the significance of occasional high
levels of hemagglutination-inhibition antibody titres in cord blood was
made. Four newborn infants were vaccinated on the fifth day of life. Two
of these had had very high titres in the serum, while the other two had had
very low titres. The two infants (A.R. and B.D.) with high antibody titres
failed to show any skin reactions at the site of vaccination, despite three
attempts at vaccination. The two (R.W. and C.O.) with low antibody
titres had a "vaccinia-take," with maximum skin reaction occurring on the
tenth day after the vaccination. Figure 2 shows the serologic response of
these four infants.
At approximately six months of age, repeat vaccinations were performed
on three of the four infants. Prior to revaccination infant A.R. had a
residual antibody titre of 1:40, while B.D. had a titre of 1:160, and infant
C.O. had a titre of 1:10. Revaccination of these three infants produced no
allergic or immune early response in patients A.R. and B.D., and resulted
in an early sensitivity response in infant C.O. followed by a typical
vaccinoid reaction, maximal on the sixth day.
Infants A.R. and B.D. developed a reaction maximal on the fifth and
sixth days, respectively. Had it not been for the absence of an early sensi-
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tivity type of reaction, indicating a lack of previous antigenic experience to
the virus, these reactions would undoubtedly be called vaccinoid. However,
in the absence of this type of sensitivity reaction and the known findings of
a high titre of passively acquired antibodies, it is suggested that these
were modified primary "vaccinia takes." A third vaccination performed on
these two children (A.R. and B.D.), at the age of one year, resulted in a
sensitivity type or immune early reaction maximal on the second day after
vaccination.
DISCUSSION
Failure to react in any way to vaccination has in the past invariably been
ascribed to faulty technique or the use of inactive inoculant. Over the years,
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FIG. 2. Hemagglutination-inhibition titres of four newborn infants at time of birth
and following vaccination at five days of age.
Three of these infants were revaccinated at around six months of age and their
antibody response shown.
however, pediatricians have pointed to instances where children did not
respond to vaccination with material known to be highly active in other
cases. The observations on two infants herein reported suggest that, at
least early in life, passively acquired immunity might, in fact, interfere with
dermal infection to live vaccinia virus and result in a true "no take." The
immediate reaction, reaching its maximum within 72 hours after vaccina-
tion, is an allergic reaction to vaccinia antigens. It denotes previous anti-
genic experience, usually through successful vaccination.1'6'7 This reaction
is not seen in unvaccinated infants but is present virtually in all revac-
cinated children.
In the absence of an early sensitivity response suggestive of previous
antigenic experience, accelerated vaccinia resembling a vaccinoid reaction
may represent modification of the infection by passively acquired immunity
present in the tissue.
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SUMMARY
1. Two newborn infants with high hemagglutination-inhibition antibody
titres in their sera could not be successfully vaccinated in the first two
weeks of life and these may represent instances of actual "no takes."
2. Two newborn infants with low hemagglutination-inhibition antibody
titres in their sera were successfully vaccinated in the first week of life and
demonstrated a rise in antibody titre.
3. At the age of six months repeat vaccination of the two infants with
high titres resulted in a skin reaction maximal on the fifth and sixth days,
respectively, in the absence of an earlier sensitivity type of reaction. This
suggests that no previous antigenic experience had occurred and that the
present response was, in fact, a modified vaccinia or accelerated primary
response. Serologic data on these patients have been presented.
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